Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison

被引:129
作者
De Meerleer, GO [1 ]
Vakaet, LAML [1 ]
De Gersem, WRT [1 ]
De Wagter, C [1 ]
De Naeyer, B [1 ]
De Neve, W [1 ]
机构
[1] State Univ Ghent Hosp, Div Radiotherapy, B-9000 Ghent, Belgium
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 47卷 / 03期
关键词
D O I
10.1016/S0360-3016(00)00419-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate whether intensity modulated radiotherapy (IMRT) by static segmented beams allows the dose to the main portion of the prostate target to escalate while keeping the maximal dose at the anterior rectal wall at 72 Gy. The value of such IMRT plans was analyzed by comparison with non-IMRT plans using the same beam incidences. Methods and Materials: We performed a planning study on the CT data of 32 consecutive patients with localized adenocarcinoma of the prostate. Three fields in the transverse plane with gantry angles of 0 degrees, 116 degrees, and 244 degrees were isocentered at the center of gravity of the target volume (prostate and seminal vesicles). The geometry of the beams was determined by beam's eye view autocontouring of the target volume with a margin of 1.5 cm. In study 1, the beam weights were determined by a human planner (3D-man) or by computer optimization using a biological objective function with (3D-optim-lim) or without (3D-optim-unlim) a physical term to limit target dose inhomogeneity. In study 2, the 3 beam incidences mentioned above were used and in-field uniform segments were added to allow IMRT. Plans with (IMRT-lim) or without (IMRT-unlim) constraints on target dose inhomogeneity were compared. In the IMRT-lim plan, target dose inhomogeneity was constrained between 15% and 20%. After optimization, plans in both studies were normalized to a maximal rectal dose of 72 Gy. Biological (tumor control probability [TCP], normal tissue complication probability [NTCP]) and physical indices for tumor control and normal tissue complication probabilities were computed, as well as the probability of the uncomplicated local control (P+). Results: The IMRT-lim plan was superior to all other plans concerning TCP (p < 0.0001). The IMRT-unlim plan had the worst TCP. Within the 3D plans, the 3D-optim-unlim had the best TCP, which was significantly different from the 3D-optim-lim plan (p = 0.0003). For rectal NTCP, both IMRT plans were superior to all other plans (p < 0.0001). The IMRT-unlim plan was significantly better than the IMRT-lim plan (p < 0.0001). Again, 3D-optim-unlim was superior to the other 3D plans (p < 0.0007). Physical endpoints for target showed the mean minimal target dose to be the lowest in the IMRT-unlim plan, caused by a large target dose inhomogeneity (TDI). Medial target dose, 90th percentile, and maximal target dose were significantly higher in both IMRT plans. Physical endpoints for the rectum showed the IMRT-unlim plan to be superior compared to all other plans. There was a strong correlation between the 65th percentile (Rp6S) and rectal NTCP (correlation coefficient greater than or equal to 89%). For bladder, maximal bladder dose was significantly higher in the IMRT-unlim plan compared to all other plans (p less than or equal to 0.0001). P+ was significantly higher in both IMRT-plans than in all other plans. The 3D-optim-unlim plan was significantly better than the two other 3D plans (p < 0.0001). Conclusion: IMRT significantly increases the ratio of TCP over NTCP of the rectum in the treatment of prostate cancer. However, constraints for TDI are needed, because a high degree of TDI reduced minimal target dose. IMRT improved uncomplicated local control probability. In our department, IMRT by static segmented beams is planned and delivered in a cost-effective way. IMRT-lim has replaced non-modulated conformal radiotherapy as the standard treatment for prostate cancer. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 39 条
  • [1] Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
    Boersma, LJ
    van den Brink, M
    Bruce, AM
    Shouman, T
    Gras, L
    te Velde, A
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01): : 83 - 92
  • [2] Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate
    Burman, C
    Chui, CS
    Kutcher, G
    Leibel, S
    Zelefsky, M
    LoSasso, T
    Spirou, S
    Wu, QW
    Yang, J
    Stein, J
    Mohan, R
    Fuks, Z
    Ling, CC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04): : 863 - 873
  • [3] FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION
    BURMAN, C
    KUTCHER, GJ
    EMAMI, B
    GOITEIN, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01): : 123 - 135
  • [4] Conformal radiotherapy of stage III non-small cell lung cancer: A class solution involving non-coplanar intensity-modulated beams
    Derycke, S
    De Gersem, WRT
    Van Duyse, BBR
    De Neve, WCJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04): : 771 - 777
  • [5] FERGUSON GA, 1981, STAT ANAL PSYCHOL ED, P142
  • [6] Results of 3D conformal radiotherapy in the treatment of localized prostate cancer
    FukunagaJohnson, N
    Sandler, HM
    McLaughlin, PW
    Strawderman, MS
    Grijalva, KH
    Kish, KE
    Lichter, AS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02): : 311 - 317
  • [7] Intensity modulated therapy and inhomogeneous dose to the tumor: A note of caution
    Goitein, M
    Niemierko, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02): : 519 - 522
  • [8] PATTERNS OF CARE STUDIES - DOSE-RESPONSE OBSERVATIONS FOR LOCAL-CONTROL OF ADENOCARCINOMA OF THE PROSTATE
    HANKS, GE
    LEIBEL, SA
    KRALL, JM
    KRAMER, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (01): : 153 - 157
  • [9] Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >=10 ng/ml
    Hanks, GE
    Lee, WR
    Hanlon, AL
    Hunt, M
    Kaplan, E
    Epstein, BE
    Movsas, B
    Schultheiss, TE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05): : 861 - 868
  • [10] Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study
    Hanks, GE
    Schultheiss, TE
    Hanlon, AL
    Hunt, M
    Lee, WR
    Epstein, BE
    Coia, LR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03): : 543 - 550